Terence Flotte to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications Terence Flotte has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.099
-
Flotte TR. Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy. Curr Opin Mol Ther. 2001 Oct; 3(5):497-502.
Score: 0.048
-
Flotte TR. Gene therapy for cystic fibrosis. Curr Opin Mol Ther. 1999 Aug; 1(4):510-6.
Score: 0.041
-
Wagner JA, Reynolds T, Moran ML, Moss RB, Wine JJ, Flotte TR, Gardner P. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus. Lancet. 1998 Jun 06; 351(9117):1702-3.
Score: 0.010